Dimethylformamide → HCID 67436034, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([N:11]([CH3:25])[CH:12]2[CH2:20][CH2:19][C:18]3[NH:17][C:16]4[CH:21]=[CH:22][CH:23]=[N:24][C:15]=4[C:14]=3[CH2:13]2)(=[O:10])=[O:9])=[CH:4][CH:3]=1.CN(C=O)C.[H-].[Na+].[C:33]([O:37][C:38](=[O:41])[CH2:39]Br)([CH3:36])([CH3:35])[CH3:34]>CO>[C:33]([O:37][C:38](=[O:41])[CH2:39][N:17]1[C:18]2[CH2:19][CH2:20][CH:12]([N:11]([S:8]([C:5]3[CH:6]=[CH:7][C:2]([F:1])=[CH:3][CH:4]=3)(=[O:10])=[O:9])[CH3:25])[CH2:13][C:14]=2[C:15]2[N:24]=[CH:23][CH:22]=[CH:21][C:16]1=2)([CH3:36])([CH3:35])[CH3:34]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 4-fluoro-N-methyl-N-(6,7,8,9-tetrahydro-5H-pyrido[3,2-b]indol-8-yl)-benzenesulfonamide (2.8 g, 7.8 mmol) and DMF (22 mL) was cooled to 0° C. Sodium hydride (340 mg, 8.6 mmol, 60% dispersion in mineral oil) was added at 0° C. and after 30 min, tert-butylbromoacetate (1.3 mL, 8.9 mmol) was added at 0° C. After 1 hour, MeOH was added and the reaction mixture was filtered. The organic layer was concentrated and the residue purified by reverse phase preparative HPLC to afford 700 mg of {8-[(4-fluoro-benzenesulfonyl)-methyl-amino]-6,7,8,9-tetrahydro-pyrido[3,2-b]indol-5-yl}-acetic acid tert-butyl ester. Mass spectrometric data [M+H]+=474.
Workup
- filtrationthe reaction mixture was filtered
- concentrationThe organic layer was concentrated
- customthe residue purified by reverse phase preparative HPLC
Sources & evidence
- ORD record
- ord-96d4224478fb4959bfe50cec541e4e77
- Source dataset
- uspto-grants-2011_10
- Patent number
- US08034826B2
Reaction notes
Loading…